Caligan Partners LP 13F Holdings

CIK 0001727492 · New York, NY

As of Jun 30, 2023, Caligan Partners LP reported 13 positions worth 77.8M in its SEC Form 13F filing.

Top 13 holdings

SecurityTickerSectorSharesValue% of portfolio
LIQUIDIA CORPLQDAHealthcare9,243,627$72.6M40.81%
ANIKA THERAPEUTICS INCANIK—720,291 8.7M10.52%
EXELIXIS INCEXELHealthcare910,730 7.4M9.79%
STANDARD BIOTOOLS INCLABHealthcare8,467,920 6.3M9.19%
INTERCEPT PHARMACEUTICALS IN——1,293,510 4.3M8.05%
INTERCEPT PHARMACEUTICALS IN——1,200,000 3.3M7.46%
EVOLUS INCEOLSHealthcare1,760,136 2.8M7.20%
VERONA PHARMA PLCVRNAHealthcare183,064$3.9M2.18%
ADMA BIOLOGICS INCADMAHealthcare847,513$3.1M1.76%
EYEPOINT PHARMACEUTICALS INCEYPTHealthcare310,298$2.7M1.52%
ALIMERA SCIENCES INCALIMHealthcare478,777 .4M0.79%
SOCIETAL CDMO INCSCTLHealthcare1,077,268 .2M0.67%
AGIOS PHARMACEUTICALS INCAGIOHealthcare4,833 36.9K0.08%